Left atrial appendage closure for stroke prevention in atrial fibrillation: State of the art and current challenges

Nature Clinical Practice Cardiovascular Medicine

Volumn 4, Issue 8, 2007, Pages 428-435

  Syed, Tariqshah M ^a   Halperin, Jonathan L ^a  

^a MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTIVITAMIN K; CLOPIDOGREL; COUMARIN; WARFARIN;

ANTICOAGULATION; CEREBROVASCULAR ACCIDENT; CLINICAL PROTOCOL; CLINICAL TRIAL; CLIP; DEVICE; DRUG EFFICACY; DRUG SAFETY; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART SURGERY; HUMAN; LEFT ATRIAL APPENDAGE CLOSURE; MONOTHERAPY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SURGICAL TECHNIQUE; THORACOSCOPY; THROMBOEMBOLISM;

ANTICOAGULANTS; ATRIAL APPENDAGE; ATRIAL FIBRILLATION; CARDIAC SURGICAL PROCEDURES; CEREBROVASCULAR ACCIDENT; CLINICAL TRIALS; HUMANS; RISK FACTORS; THORACOSCOPY;

EID: 34547497128     PISSN: 17434297     EISSN: 17434300     Source Type: Journal    
DOI: 10.1038/ncpcardio0933     Document Type: Review

References (64)

1. Go AS et al. (2001) Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 285: 2370-2375
2. Lloyd-Jones DM et al. (2004) Lifetime risk for development of atrial fibrillation: The Framingham Heart Study. Circulation 110: 1042-1046
3. Psaty BM et al. (1997) Incidence of and risk factors for atrial fibrillation in older adults. Circulation 96: 2455-2461
4. Krahn AD et al. (1995) The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med 98: 476-484
5. Frost L et al. (2000) Incident stroke after discharge from the hospital with a diagnosis of atrial fibrillation. Am J Med 108 36-40
6. Wolf PA et al. (1991) Atrial fibrillation as an independent risk factor for stroke: The Framingham Study. Stroke 22: 983-988
7. Lake FR et al. (1989) Atrial fibrillation and mortality in an elderly population. Aust NZJ Med 19: 321-326
8. Phillips SJ et al. (1990) Prevalence of cardiovascular disease and diabetes mellitus in residents of Rochester, Minnesota. Mayo Clin Proc 65: 344-359
9. Furberg CD et al. (1994) Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). Am J Cardiol 74: 236-241
10. Miyasaka Y et al. (2006) Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 114: 119-125
11. Anderson DC et al. (2002) Occurrence of hemispheric and retinal ischemia in atrial fibrillation compared with carotid stenosis. Stroke 33: 1963-1967
12. Harrison MJ and Marshall J (1984) Atrial fibrillation, TIAs and completed strokes. Stroke 15: 441-442
13. Gage BF et al. (2001) Validation of clinical classification schemes for predicting stroke: Results from the National Registry of Atrial Fibrillation. JAMA 285: 2864-2870
14. Israel CW et al. (2004) Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device: implications for optimal patient care. J Am Coll Cardiol 43: 47-52
15. Page RL et al. (1994) Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia. Circulation 89: 224-227
16. Rockson SG and Albers GW (2004) Comparing the guidelines: anticoagulation therapy to optimize stroke prevention in patients with atrial fibrillation. J Am Coll Cardiol 43: 929-935
17. Gage BF et al. (2004) Selecting patients with atrial fibrillation for anticoagulation: Stroke risk stratification in patients taking aspirin. Circulation 110: 2287-2292
18. Go AS et al. (2003) Anticoagulation therapy for stroke prevention in atrial fibrillation: How well do randomized trials translate into clinical practice? JAMA 290: 2685-2692
19. The SPAF III Writing Committee for the Stroke Prevention in Atrial Fibrillation Investigators (1998) Patients with nonvalvular atrial fibrillation at low risk of stroke during treatment with aspirin: Stroke Prevention in Atrial Fibrillation III Study. JAMA 279: 1273-1277
20. Wang TJ et al. (2003) A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: The Framingham Heart Study. JAMA 290: 1049-1056
21. The Stroke Prevention in Atrial Fibrillation Investigators (1992) Predictors of thromboembolism in atrial fibrillation. II: echocardiographic features of patients at risk. Ann Intern Med 116: 6-12
22. Singer DE et al. (2004) Antithrombotic therapy in atrial fibrillation: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126 (Suppl 3): 429S-456S
23. Ezekowitz MD and Levine JA (1999) Preventing stroke in patients with atrial fibrillation. JAMA 281: 1830-1835
24. Atrial Fibrillation Investigators (1994) Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 154: 1449-1457
25. Gottlieb LK and Salem-Schatz S (1994) Anticoagulation in atrial fibrillation: Does efficacy in clinical trials translate into effectiveness in practice? Arch Intern Med 154: 1945-1953
26. Wehinger C et al. (2001) Evaluation of risk factors for stroke/ embolism and of complications due to anticoagulant therapy in atrial fibrillation. Stroke 32: 2246-2252
27. Fihn SD et al. (1996) The risk for and severity of bleeding complications in elderly patients treated with warfarin. The National Consortium of Anticoagulation Clinics. Ann Intern Med 124: 970-979
28. The Stroke Prevention in Atrial Fibrillation Investigators (1991) Stroke Prevention in Atrial Fibrillation Study: Final results. Circulation 84: 527-539
29. Gage BF et al. (2006) Clinical classification schemes for predicting hemorrhage: Results from the National Registry of Atrial Fibrillation (NRAF). Am Heart J 151: 713-719
30. Bungard TJ et al. (2000) Why do patients with atrial fibrillation not receive warfarin? Arch Intern Med 160: 41-46
31. Sadler TW and Langman J (2006) Langman's Medical Embryology, edn 10. New York: Lippincott Williams & Wilkins
32. Ernst G et al. (1995) Morphology of the left atrial appendage. Anat Rec 242: 553-561
33. Subramaniam B et al. (2006) Transesophageal echocardiographic assessment of right atrial appendage anatomy and function: Comparison with the left atrial appendage and implications for local thrombus formation. J Am Soc Echocardiogr 19: 429-433
34. Veinot JP et al. (1997) Anatomy of the normal left atrial appendage: A quantitative study of age-related changes in 500 autopsy hearts: Implications for echocardiographic examination. Circulation 96: 3112-3115
35. Tabata T et al. (1998) Role of left atrial appendage in left atrial reservoir function as evaluated by left atrial appendage clamping during cardiac surgery. Am J Cardiol 81: 327-332
36. Rodeheffer RJ et al. (1993) Molecular forms of atrial natriuretic factor in normal and failing human myocardium. Circulation 88 364-371
37. Davis CA III et al. (1990) Compliance of left atrium with and without left atrium appendage. Am J Physiol 259: H1006-H1008
38. Hoit BD and Walsh RA (1992) Regional atrial distensibility. Am J Physiol 262: H1356-H1360
39. Hoit BD et al. (1993) Altered left atrial compliance after atrial appendectomy: Influence on left atrial and ventricular filling. Circ Res 72: 167-175
40. Hondo T et al. (1995) The role of the left atrial appendage: A volume loading study in open-chest dogs. Jpn Heart J 36: 225-234
41. Kamalesh M et al. (2000) Effect of inotropic stimulation on left atrial appendage function in atrial myoparthy of chronic atrial fibrillation. Echocardiography 17: 313-318
42. Pollick C (2000) Left atrial appendage myopathy: The importance of serial transesophageal assessment in atrial fibrillation. Chest 117: 297-298
43. Blackshear JL and Odell JA (1996) Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg 61: 755-759
44. Garcia-Fernandez MA et al. (2003) Role of left atrial appendage obliteration in stroke reduction in patients with mitral valve prosthesis: A transesophageal echocardiographic study. J Am Coll Cardiol 42: 1253-1258
45. Katz ES et al. (2000) Surgical left atrial appendage ligation is freguently incomplete: A transesophageal echocardiograhic study. J Am Coll Cardiol 36: 468-471
46. Johnson WD et al. (2000) The left atrial appendage: Our most lethal human attachment! Surgical implications. Eur J Cardiothorac Surg 17: 718-722
47. Bonow RO et al. (2006) ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol 48: e1-e148
48. Blackshear JL et al. (2003) Thoracoscopic extracardiac obliteration of the left atrial appendage for stroke risk reduction in atrial fibrillation. J Am Coll Cardiol 42: 1249-1252
49. Healey JS et al. (2005) Left Atrial Appendage Occlusion Study (LAAOS): Results of a randomized controlled pilot study of left atrial appendage occlusion during coronary bypass surgery in patients at risk for stroke. Am Heart J 150: 288-293
50. Kamohara K et al. (2006) Evaluation of a novel device for left atrial appendage exclusion: The second-generation atrial exclusion device. J Thorac Cardiovasc Surg 132: 340-346
51. Bayard YL et al. (2005) Transcatheter occlusion of the left atrial appendage for stroke prevention. Expert Rev Cardiovasc Ther 3 1003-1008
52. Meier B et al. (2003) Transcatheter left atrial appendage occlusion with Amplatzer devices to obviate anticoagulation in patients with atrial fibrillation. Catheter Cardiovasc Interv 60: 417-422
53. Bass JL et al. (2003) Initial human experience with the Amplatzer perimembranous ventricular septal occluder device. Catheter Cardiovasc Interv 58: 238-245
54. Nakai T et al. (2002) Percutaneous left atrial appendage occlusion (PLAATO) for preventing cardioembolism: First experience in canine model. Circulation 105: 2217-2222
55. Sievert H et al. (2002) Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in high-risk patients with atrial fibrillation: Early clinical experience. Circulation 105 1887-1889
56. Himbert D et al. (2006) Feasibility of percutaneous exclusion of the left atrial appendage: Results of 11 cases [French]. Arch Mal Coeur Vaiss 99: 585-592
57. Ussia GP et al. (2006) Percutaneous left atrial appendage transcatheter occlusion in patients with chronic nonvalvular atrial fibrillation: Early institutional experience. J Cardiovasc Med (Hagerstown) 7: 569-572
58. Omran H et al. (2005) Post mortem analysis of a left atrial appendage occlusion device (PLAATO) in a patient with permanent atrial fibrillation. J Interv Card Electrophysiol 14: 17-20
59. Ostermayer SH et al. (2005) Percutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation: Results from the international multi-center feasibility trials. J Am Coll Cardiol 46: 9-14
60. Hanna IR et al. (2004) Left atrial structure and function after percutaneous left atrial appendage transcatheter occlusion (PLAATO): six-month echocardiographic follow-up. J Am Coll Cardiol 43: 1868-1872
61. Connolly S et al. for the ACTIVE Writing Group on behalf of the ACTIVE Investigators (2006) Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): A randomised controlled trial. Lancet 367: 1903-1912
62. Fountain RB et al. (2006) The PROTECT AF (WATCHMAN Left Atrial Appendage System for Embolic PROTECTion in Patients with Atrial Fibrillation) trial. Am Heart J 151: 956-961
63. Stollberger C et al. (2007) Serious complications from dislocation of a Watchman left atrial appendage occluder. J Cardiovasc Electrophysiol [doi: 10.1111/j.1540-8167.2007.00784.x]
64. Krumsdorf U et al. (2004) Incidence and clinical course of thrombus formation on atrial septal defect and patient foramen ovale closure devices in 1,000 consecutive patients. J Am Coll Cardiol 43: 302-309